BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 25818101)

  • 1. Epicardial Fat in Nonalcoholic Fatty Liver Disease: Properties and Relationships With Metabolic Factors, Cardiac Structure, and Cardiac Function.
    Psychari SN; Rekleiti N; Papaioannou N; Varhalama E; Drakoulis C; Apostolou TS; Iliodromitis EK
    Angiology; 2016 Jan; 67(1):41-8. PubMed ID: 25818101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epicardial adipose tissue relating to anthropometrics, metabolic derangements and fatty liver disease independently contributes to serum high-sensitivity C-reactive protein beyond body fat composition: a study validated with computed tomography.
    Lai YH; Yun CH; Yang FS; Liu CC; Wu YJ; Kuo JY; Yeh HI; Lin TY; Bezerra HG; Shih SC; Tsai CH; Hung CL
    J Am Soc Echocardiogr; 2012 Feb; 25(2):234-41. PubMed ID: 22014839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epicardial fat, cardiac geometry and cardiac function in patients with non-alcoholic fatty liver disease: association with the severity of liver disease.
    Petta S; Argano C; Colomba D; Cammà C; Di Marco V; Cabibi D; Tuttolomondo A; Marchesini G; Pinto A; Licata G; Craxì A
    J Hepatol; 2015 Apr; 62(4):928-33. PubMed ID: 25445395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Nonalcoholic Fatty Liver Disease Fibrosis Score Is Related to Epicardial Fat Thickness and Complexity of Coronary Artery Disease.
    Turan Y
    Angiology; 2020 Jan; 71(1):77-82. PubMed ID: 31018673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Influence of Epicardial Fat and Nonalcoholic Fatty Liver Disease on Heart Rate Recovery in Metabolic Syndrome.
    Cho KI; Jo EA; Cho SH; Kim BH
    Metab Syndr Relat Disord; 2017 Jun; 15(5):226-232. PubMed ID: 28346857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of epicardial fat volume and nonalcoholic fatty liver disease with metabolic syndrome: From the CAESAR study.
    Kim BJ; Kim HS; Kang JG; Kim BS; Kang JH
    J Clin Lipidol; 2016; 10(6):1423-1430.e1. PubMed ID: 27919360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epicardial fat thickness and nonalcoholic fatty liver disease in obese subjects.
    Iacobellis G; Barbarini G; Letizia C; Barbaro G
    Obesity (Silver Spring); 2014 Feb; 22(2):332-6. PubMed ID: 24115757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of epicardial adipose tissue and carotid intima-media thickness in patients with nonalcoholic fatty liver disease.
    Colak Y; Karabay CY; Tuncer I; Kocabay G; Kalayci A; Senates E; Ozturk O; Doganay HL; Enc FY; Ulasoglu C; Kiziltas S
    Eur J Gastroenterol Hepatol; 2012 Jun; 24(6):613-8. PubMed ID: 22495402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between epicardial adipose tissue, high-sensitivity C-reactive protein and myocardial dysfunction in middle-aged men with suspected metabolic syndrome.
    Cho DH; Joo HJ; Kim MN; Lim DS; Shim WJ; Park SM
    Cardiovasc Diabetol; 2018 Jun; 17(1):95. PubMed ID: 29960588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between nonalcoholic fatty liver disease and cardiovascular risk in obese children and adolescents.
    Alp H; Karaarslan S; Selver Eklioğlu B; Atabek ME; Altın H; Baysal T
    Can J Cardiol; 2013 Sep; 29(9):1118-25. PubMed ID: 23040432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Quantity of Liver Fat and Cardiovascular Risk in Patients With Nonalcoholic Fatty Liver Disease Independent of Nonalcoholic Steatohepatitis.
    Arulanandan A; Ang B; Bettencourt R; Hooker J; Behling C; Lin GY; Valasek MA; Ix JH; Schnabl B; Sirlin CB; Loomba R
    Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1513-20.e1. PubMed ID: 25661453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epicardial Adipose Tissue (EAT) Thickness Is Associated with Cardiovascular and Liver Damage in Nonalcoholic Fatty Liver Disease.
    Fracanzani AL; Pisano G; Consonni D; Tiraboschi S; Baragetti A; Bertelli C; Norata GD; Dongiovanni P; Valenti L; Grigore L; Tonella T; Catapano A; Fargion S
    PLoS One; 2016; 11(9):e0162473. PubMed ID: 27627804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-Analysis of Non-Alcoholic Fatty Liver Disease and Electromechanical Reconstruction of Myocardium.
    Tretyakova VA; Zhernakova NI; Arisheva OS; Garmash IV; Tretyakov A; Gerasimov NI; Ermilov OV
    Arch Razi Inst; 2022 Feb; 77(1):135-140. PubMed ID: 35891721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased severity of liver fat content and liver fibrosis in non-alcoholic fatty liver disease correlate with epicardial fat volume in type 2 diabetes: A prospective study.
    Brouha SS; Nguyen P; Bettencourt R; Sirlin CB; Loomba R
    Eur Radiol; 2018 Apr; 28(4):1345-1355. PubMed ID: 29058029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of epicardial adipose tissue (EAT) thickness and anthropometric measurements in metabolic syndrome (MS) cases above and under the age of 65.
    Karadag B; Ozulu B; Ozturk FY; Oztekin E; Sener N; Altuntas Y
    Arch Gerontol Geriatr; 2011; 52(2):e79-84. PubMed ID: 20705350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind, placebo-controlled randomized trial to evaluate the efficacy of docosahexaenoic acid supplementation on hepatic fat and associated cardiovascular risk factors in overweight children with nonalcoholic fatty liver disease.
    Pacifico L; Bonci E; Di Martino M; Versacci P; Andreoli G; Silvestri LM; Chiesa C
    Nutr Metab Cardiovasc Dis; 2015 Aug; 25(8):734-41. PubMed ID: 26026214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of clinical and inflammatory markers of nonalcoholic fatty liver disease in postmenopausal women with metabolic syndrome.
    Rodrigues MH; Bruno AS; Nahas-Neto J; Sandrim VC; Muniz LG; Nahas EA
    Metab Syndr Relat Disord; 2014 Aug; 12(6):330-8. PubMed ID: 25051240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diastolic dysfunction and cardiovascular risk in old subjects: possible association with NAFLD?
    Gianotti G; Cenni A; Bianchi G; Masetti M; Zappoli P; Muscari A; Zoli M;
    Arch Gerontol Geriatr; 2014; 58(2):188-95. PubMed ID: 24268461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.
    Alkassabany YM; Farghaly AG; El-Ghitany EM
    Arab J Gastroenterol; 2014 Jun; 15(2):76-81. PubMed ID: 25097051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease.
    Ayonrinde OT; Olynyk JK; Beilin LJ; Mori TA; Pennell CE; de Klerk N; Oddy WH; Shipman P; Adams LA
    Hepatology; 2011 Mar; 53(3):800-9. PubMed ID: 21374659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.